(Date:11/27/2009)..., , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstC...announced that Blair Lambert, CFO/COO, will presen...ill be held at the May Fair Hotel in London, Engla...GMT. ,, To listen to a live broadcast of The Gy...t, please log on to www.gymboree.com, click on "Ou...
(Date:11/27/2009)..., , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswi...daq: SHMR ) ( "Shamir" ), a leading provider of i...c lens market, announced today that its board of d...n aggregate amount of US$ 10 million (approximatel... representative rate of exchange), or approximatel...
(Date:11/27/2009)...aring rates to bring unprecedented medical, econom...ov. 27 (HealthDay News) -- The number of people wi...uble over the next 25 years, a new study predicts....44.1 million people with the disease, up from 23.7...f treating people with diabetes will triple, the s...
(Date:11/27/2009)... Multi-purpose bilingual co...esigned for use by the business community to educa...y of subjects from Safety issues to Dinosuars to A... Saint Louis, MO (PRWEB) November 27, 200...lectronics or toys to keep them busy any hour of t...
(Date:11/26/2009)..., , NEW YORK, Nov. 27 With c...an ever to employ good practices to control the sp...ed to be proactive not only to keep ourselves heal...ck," said Eileen Finerty, RN, MS, CIC (certified i...on control and occupational health at Hospital for...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4...ood and Drug Administration (FDA) are discussing h...t possible to collect better data about experiment...quirements. , Researchers from the National Insti...efore an audience of their peers on November 28-29...
...stitute for Brain Research will head an ambitious ...lexia, supported by a $8.5M grant from the Ellison...nwisher and John Gabrieli, are prominent experts i...cial interactions and communication, and affected ...
...X:,ROG.VX; RO.S; OTCQX; RHHBY) announced today tha...antitrust laws, it is not aware of any such law,th...ares tendered pursuant,to its outstanding Offer to..., Roche intends to accept for payment Ventana,shar...
...nc.,(Nasdaq: ABAX ), a medical products company m... today reported financial results for the fiscal,q...r the third quarter of fiscal 2008 include:, -- ...ble quarter. -- Piccolo instrument sales of 238 ...
...euticals, Inc. (OTC Bulletin Board: ACPH) is pleas... approved the Company,s application to,list its co...Q"). The,Company,s common stock will commence trad...ading on NASDAQ," stated Andy Reddick, the Company...
...s AmeriHealth Mercy,s product offerin...A, Jan. 31 The AmeriHealth Mercy Family of,Compan...ounced today that,it has acquired Community Behavi...now a wholly owned subsidiary of,AmeriHealth Mercy...
Other Medicine News:Health News:Researchers query FDA about updating requirements for drug approval 2Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:Roche Plans to Complete Ventana Offer on February 7th 2Health News:Roche Plans to Complete Ventana Offer on February 7th 3Health News:Roche Plans to Complete Ventana Offer on February 7th 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 2Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 3Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 4Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 5Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 6Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 7Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 8Health News:Abaxis Reports Record Sales for the Third Quarter of Fiscal 2008 9Health News:Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR 2Health News:AmeriHealth Mercy Family of Companies Acquires Community Behavioral HealthCare Network of Pennsylvania 2(Date:11/25/2009)...NSWICK, N.J., Nov. 25 Swissray Int...digital Radiography ( ddR ) systems, announced tod...vate Swiss Investor with a long term view towards ...isition included all assets and intellectual prope...years of success and growth Swissray is now poised...
(Date:11/25/2009)...ORK, Nov. 25 Reportlinker.com anno...le in its catalogue: ,, Pain Management - Glo...164220/Pain-Management---Global-Trends.html ,,...ce of pain management clinics, and the advent of n...e pain management market. Healthcare reforms and r...
(Date:11/25/2009)...W, Calif., Nov. 25 ChemoCentryx,...data from the Company,s PROTECT-1 (the Prospective...ease Trial) of Traficet-EN(TM) (CCX282-B) in patie...trated clinical efficacy with a favorable safety a...vidence of clinical efficacy in the reduction of d...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Despite claims UK did not gas Iraqis in the 1920s new research finds 10470 1Despite claims UK did not gas Iraqis in the 1920s new research finds 10470 2Despite claims UK did not gas Iraqis in the 1920s new research finds 10470 3Despite claims UK did not gas Iraqis in the 1920s new research finds 10470 4Widely used virus assay shown unreliable when compared to other methods 10467 1Widely used virus assay shown unreliable when compared to other methods 10467 2For Obese Weight Gained in Pregnancy May Not Leave 59939 1For Obese Weight Gained in Pregnancy May Not Leave 59939 2For Obese Weight Gained in Pregnancy May Not Leave 59939 3..., exenatide offered added benefits of, weight los...etformin --, AMSTERDAM, Netherlands, Sept. 21 Am...i Lilly and Company (NYSE: LLY ),today announced ...ection,with insulin glargine on beta-cell function...2 diabetes. Study findings showed one year of exen...
...atients at Beaumont,Hospitals are the first in the...adiation therapy that is painless, faster, more ac...t doctors and physicists invented and patented the...hine is manufactured in,England by Elekta, which i...s treated on Sept. 10. The painless treatment tak...
Other Medicine Technology:One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7Beaumont Patients 1st to get Next Generation of Radiation Treatment 26.00mm Open Trephine Handle
5.50mm Open Trephine Handle
5.00mm Open Trephine Handle
Adjustable Troutman Trephine Handle, Fits 7mm - 9mm trephines
Medicine Products: